Swoop® Portable MR Imaging® System (V2)

The Swoop® Portable MR Imaging® System (V2) is an ultra-low field, Class II magnetic resonance imaging device designed for head imaging, particularly when traditional full diagnostic examinations are impractical. Through extensive non-clinical performance testing and a determination of substantial equivalence, the device aims to provide clinicians with portable imaging capabilities for diagnostic information.

A review has been completed for the Swoop® Portable MR Imaging® System (V2) manufactured by Hyperfine, Inc. This review determined that the device is substantially equivalent to legally marketed devices for its stated indications for use. As a result, Hyperfine, Inc. may market the device, provided it adheres to applicable general controls and other regulatory provisions. The Swoop® Portable MR Imaging® System (V2) is a Class II, portable, ultra-low field magnetic resonance imaging device intended for producing images that display the internal structure of the head. These images are to be used when a full diagnostic examination is not clinically practical, and they can provide information useful for diagnosis when interpreted by a trained physician. The system was deemed substantially equivalent to a previous version, with testing confirming that hardware and software differences do not introduce new questions of safety or efficacy. This conclusion was supported by extensive non-clinical performance testing, including verification, validation, biocompatibility, reprocessing, safety, and advanced reconstruction analysis.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What specific clinical scenarios render a "full diagnostic examination not clinically practical," where the Swoop system would be utilized?; How does the image quality and diagnostic utility of the ultra-low field Swoop system compare quantitatively to conventional high-field MRI systems for various head pathologies?; What are the long-term clinical outcomes and patient benefits observed from diagnoses made using the Swoop system, particularly in underserved or remote settings?; What are the limitations of the Swoop system in detecting subtle brain lesions or specific pathologies that are typically well-visualized by higher-field MRI?; Has there been any post-market surveillance data collected regarding the safety and efficacy of the Swoop system, especially concerning its portable nature and use in diverse environments?